Aspects of Quality of Life in Gastrointestinal Disease: Some Methodological Issues

References

• Guyatt G, Veldhuyzen van Zanten S, Feeny D, et al. Measuring Quality of Life in clinical trials: a taxonomy and review. Can Med Assoc J 1989; 140: 1441–8
   PubMed Web of Science ®Google Scholar
• Palmore E, Linkhardt C. Health and social factors related to life satisfaction. J Health Soc Behav 1972; 13: 68–80
   PubMed Web of Science ®Google Scholar
• Spitzer WO. State of science 1986;Quality of Life and functional status as target variables for research. J Chron Dis 1987; 40: 465–71
   PubMedGoogle Scholar
• Fitzpatrick R, Fletcher A, Gore S, Jones D, Spiegelhalter D, Cox D. Quality of Life measures in health care. I: Applications and issues in assessment. Br Med J 1992; 305: 1074–7
   PubMed Web of Science ®Google Scholar
• Hallerbäck B, Glise H, Hernqvist H., In preparation
   Google Scholar
• Glise H, Hallerbäck B, Johansson B. Laparoscopic Rosetti fundoplication. Scand J Gastroenterol 1995; 30: 58–61, Suppl 208
   Google Scholar
• Revicki D A, Rothman M, Luce B. Health-related Quality of Life assessments and the pharmaceutical industry. Pharmaco-economics 1992; 6: 394–408
   Google Scholar
• Hillman A L, Bloom B S, Fendrick A M, Schwartz JS. Cost and quality effects of alternative treatments for persistent gastroesophageal reflux disease. Arch Intern Med 1992; 152: 1467–72
   PubMedGoogle Scholar
• Jonsson B, Stålhammar N-O. The cost-effectiveness of omeprazole and ranitidine in intermittent and maintenance treatment of reflux esophagitis-the case of Sweden. Br J Med Econ 1993; 6: 111–26
   Google Scholar
• Bate C M, Richardsson P DI. A one year model for the cost-effectiveness of treating reflux esophagitis. Br J Med Econ 1992; 2: 5–11
   Google Scholar
• Sintonen H, Alander V. Comparing the cost-effectiveness of drug regimens in the treatment of duodenal ulcers. J Health Econ 1990; 9: 85–101
   PubMed Web of Science ®Google Scholar
• Fallowfleld L, Baum M, Maguire GP. Do psychological studies upset patients?. J Roy Soc Med 1987; 80: 59
   Google Scholar
• Kirscbner B, Guyatt G. A methodological framework for assessing health indices. J Chron Dis 1985; 38: 27–36
   PubMedGoogle Scholar
• Cox D R, Fitzpatrick R, Fletcher A E, et al. Quality of Life assessment: Can we keep it simple?. J R Statis Soc 1992; 155: 353–93
   Google Scholar
• Aaronson NK. Quality of Life assessments in clinical trials: methodological issues. Contr Clin Trials 1989; 10: 195S–208S
   PubMedGoogle Scholar
• Aaronson NK. Assessing the Quality of Life in patients in cancer clinical trials: common sense problems and common sense solutions. Eur J Cancer 1992; 28A: 1304–7
   PubMed Web of Science ®Google Scholar
• Wiklund I, Dimenäs E, Wahl M. Factors of importance when evaluating Quality of Life in clinical trials. Contr Clin Trials 1990; 11: 169–79
   PubMedGoogle Scholar
• Veldhuyzen van Zanten S JO, Tytgat K MAJ, Jalali S, Goodacre R L, Hunt RH. Can gastritis symptoms be evaluated in clinical trials? An overview of treatment of gastritis, non-ulcer dyspepsia and Campylobacter-associated gastritis. J Clin Gastroenterol 1989; 11: 496–501
   PubMedGoogle Scholar
• Guyatt G, Mitchell A, Irvine E J, Singer J, Williams N, Goodacre R, et al. A new measure of health status for clinical trials in inflammatory bowel disease. Gastroenterol 1989; 96: 804–10
   PubMed Web of Science ®Google Scholar
• Drossman D A, Leserman J, Li Z M, Mitchell cm Zagami E A, Patrick DL. The rating form of IBD patients concerns: a new measure of health status. Psychosom Med 1991; 53: 701–12
   PubMed Web of Science ®Google Scholar
• Talley N J, Phillips S F, Melton J, 3d, Wiltgen C, Zinsmeister AR. A patient questionnaire to identify bowel diasease. Ann Intern Med 1989; 111: 671–4
   PubMed Web of Science ®Google Scholar
• Dimenäs E, Glise H, Hallerbäck B, Hernqvist H, Svedlund J, Wiklund I. Quality of Life in patients with upper gastrointestinal symptoms. An improved evaluation of treatment regimens?. Scand J Gastroenterol 1993; 28: 681–7
   PubMed Web of Science ®Google Scholar
• Dimenäs E, Glise H, Hallerbäck B, et al. Well-being and gastrointestinal symptoms among patients referred to endoscopy due to suspected duodenal ulcer, Submitted
   Google Scholar
• Abell T L, Cutts T F, Cooper T. Effect of cisapride therapy for severe dyspepsia on gastrointestinal symptoms and Quality of Life. Scand J Gastroenterol 1993; 195: 60–4
   Google Scholar
• Wiklund I, Karlberg J. Evaluation of Quality of Life in clinical trials: selecting Quality of Life measures. Contr Clin Trials 1991; 12: 204S–216S, Suppl
   PubMedGoogle Scholar
• Smith ND. Quality of Life studies from the perspective of an FDA reviewing statistician. Drug Inf J 1993; 27: 617–623
   Google Scholar
• MacDonald A J, Peden N R, Hayton R, Mallinson C N, Roberts D, Wormsley KG. Symptom relief and the placebo effect in the trial of an anti-peptic drug. Gut 1981; 22: 323–6
   PubMedGoogle Scholar
• Gotthard R, Bodemar G, Brodin U, Jönsson KA. Treatment with cimetidine, antacid, or placebo in patients with dyspepsia of unknown origin. Scand J Gastroenterol 1988; 23: 7–18
   PubMed Web of Science ®Google Scholar
• Frank W O, Young M, Palmer R H, Karlstadt R, Rockhold F, Mounce W. Once-daily bedtime dosing regimen of cimetidine in the treatment of gastric ulcer. Clin Ther 1989; 11: 595–603
   PubMedGoogle Scholar
• De Nutte N, Van Ganse W, Witterhulghe M, Defrance P. Relief of epigastric pain in non-ulcer dyspepsia: controlled trial of the promotility drug cisapride. Clin Ther 1989; 11: 62–8
   PubMedGoogle Scholar
• Cloud M L, Offen W W, Robinson M. Nizatidine versus placebo in gastroesophageal reflux disease; a 12-week, multicenter, randomized, double-blind study. Am J Gastroenterol 1991; 86: 1735–42
   PubMedGoogle Scholar
• Fletcher A, Gore S, Jones D, Fitzpatrick R, Spigelhalter D, Cox D. Quality of Life measures in health care. II: Design, analysis, and interpretation. BMJ 1992; 305: 1145–8
   PubMedGoogle Scholar
• Agreus L. Socio-economic factors, health care consumption and rating of abdominal symptom severity. A report from the abdominal symptom study. Fam Pract 1993; 10: 152–63
   PubMed Web of Science ®Google Scholar
• Talley N J, Zinsmeister A R, Van Dyke C, Melton LJ, 3d. Epidemiology of colonic symptoms and the irritable bowel syndrome. Gastroenterology 1991; 101: 927–34
   PubMed Web of Science ®Google Scholar
• Talley N J, Zinsmeister A R, Schleck C D, Melton LJ, 3d. Dyspepsia and dyspepsia subgroups: a population-based study. Gastroenterology 1992; 102: 1259–68
   PubMed Web of Science ®Google Scholar